Research ArticleArticle
Longterm Work Productivity Costs Due to Absenteeism and Permanent Work Disability in Patients with Early Rheumatoid Arthritis: A Nationwide Register Study of 7831 Patients
Janne A. Martikainen, Hannu Kautiainen, Vappu Rantalaiho and Kari T. Puolakka
The Journal of Rheumatology October 2016, jrheum.160103; DOI: https://doi.org/10.3899/jrheum.160103
Janne A. Martikainen
From the Pharmacoeconomics and Outcomes Research Unit (PHORU), School of Pharmacy, University of Eastern Finland, Kuopio; Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki; Unit of Primary Health Care, Turku University Hospital, Turku; Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital; School of Medicine, University of Tampere, Tampere; South-Karelia Central Hospital, Lappeenranta, Finland. Supported by a grant from the Yrjö Jahnsson Foundation (grant number 6575). J.A. Martikainen, PhD, Associate Professor, PHORU, School of Pharmacy, University of Eastern Finland; H. Kautiainen, BSc, Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, and Unit of Primary Health Care, Turku University Hospital; V. Rantalaiho, MD, PhD, Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital, and School of Medicine, University of Tampere; K.T. Puolakka, MD, PhD, South- Karelia Central Hospital. Address correspondence to Dr. J. Martikainen, Associate Professor, Pharmacoeconomics and Outcomes Research Unit (PHORU), School of Pharmacy, University of Eastern Finland, Kuopio, Finland. E-mail: janne.martikainen@uef.fi. Accepted for publication August 27, 2016.
Hannu Kautiainen
From the Pharmacoeconomics and Outcomes Research Unit (PHORU), School of Pharmacy, University of Eastern Finland, Kuopio; Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki; Unit of Primary Health Care, Turku University Hospital, Turku; Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital; School of Medicine, University of Tampere, Tampere; South-Karelia Central Hospital, Lappeenranta, Finland. Supported by a grant from the Yrjö Jahnsson Foundation (grant number 6575). J.A. Martikainen, PhD, Associate Professor, PHORU, School of Pharmacy, University of Eastern Finland; H. Kautiainen, BSc, Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, and Unit of Primary Health Care, Turku University Hospital; V. Rantalaiho, MD, PhD, Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital, and School of Medicine, University of Tampere; K.T. Puolakka, MD, PhD, South- Karelia Central Hospital. Address correspondence to Dr. J. Martikainen, Associate Professor, Pharmacoeconomics and Outcomes Research Unit (PHORU), School of Pharmacy, University of Eastern Finland, Kuopio, Finland. E-mail: janne.martikainen@uef.fi. Accepted for publication August 27, 2016.
Vappu Rantalaiho
From the Pharmacoeconomics and Outcomes Research Unit (PHORU), School of Pharmacy, University of Eastern Finland, Kuopio; Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki; Unit of Primary Health Care, Turku University Hospital, Turku; Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital; School of Medicine, University of Tampere, Tampere; South-Karelia Central Hospital, Lappeenranta, Finland. Supported by a grant from the Yrjö Jahnsson Foundation (grant number 6575). J.A. Martikainen, PhD, Associate Professor, PHORU, School of Pharmacy, University of Eastern Finland; H. Kautiainen, BSc, Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, and Unit of Primary Health Care, Turku University Hospital; V. Rantalaiho, MD, PhD, Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital, and School of Medicine, University of Tampere; K.T. Puolakka, MD, PhD, South- Karelia Central Hospital. Address correspondence to Dr. J. Martikainen, Associate Professor, Pharmacoeconomics and Outcomes Research Unit (PHORU), School of Pharmacy, University of Eastern Finland, Kuopio, Finland. E-mail: janne.martikainen@uef.fi. Accepted for publication August 27, 2016.
Kari T. Puolakka
From the Pharmacoeconomics and Outcomes Research Unit (PHORU), School of Pharmacy, University of Eastern Finland, Kuopio; Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki; Unit of Primary Health Care, Turku University Hospital, Turku; Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital; School of Medicine, University of Tampere, Tampere; South-Karelia Central Hospital, Lappeenranta, Finland. Supported by a grant from the Yrjö Jahnsson Foundation (grant number 6575). J.A. Martikainen, PhD, Associate Professor, PHORU, School of Pharmacy, University of Eastern Finland; H. Kautiainen, BSc, Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, and Unit of Primary Health Care, Turku University Hospital; V. Rantalaiho, MD, PhD, Department of Internal Medicine, Centre for Rheumatic Diseases, Tampere University Hospital, and School of Medicine, University of Tampere; K.T. Puolakka, MD, PhD, South- Karelia Central Hospital. Address correspondence to Dr. J. Martikainen, Associate Professor, Pharmacoeconomics and Outcomes Research Unit (PHORU), School of Pharmacy, University of Eastern Finland, Kuopio, Finland. E-mail: janne.martikainen@uef.fi. Accepted for publication August 27, 2016.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Longterm Work Productivity Costs Due to Absenteeism and Permanent Work Disability in Patients with Early Rheumatoid Arthritis: A Nationwide Register Study of 7831 Patients
Janne A. Martikainen, Hannu Kautiainen, Vappu Rantalaiho, Kari T. Puolakka
The Journal of Rheumatology Oct 2016, jrheum.160103; DOI: 10.3899/jrheum.160103
Longterm Work Productivity Costs Due to Absenteeism and Permanent Work Disability in Patients with Early Rheumatoid Arthritis: A Nationwide Register Study of 7831 Patients
Janne A. Martikainen, Hannu Kautiainen, Vappu Rantalaiho, Kari T. Puolakka
The Journal of Rheumatology Oct 2016, jrheum.160103; DOI: 10.3899/jrheum.160103